Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 11, Issue 12, Pages 1939-1954
Publisher
Informa Healthcare
Online
2014-07-18
DOI
10.1517/17425247.2014.941803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer
- (2014) Mehdi Evazalipour et al. Contrast Media & Molecular Imaging
- Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
- (2014) Matt Shirley et al. DRUGS
- Molecular Imaging with Macrophage CRIg-Targeting Nanobodies for Early and Preclinical Diagnosis in a Mouse Model of Rheumatoid Arthritis
- (2014) F. Zheng et al. JOURNAL OF NUCLEAR MEDICINE
- Improved Tumor Targeting of Anti-HER2 Nanobody Through N-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling
- (2014) M. Pruszynski et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted Radionuclide Therapy with A 177Lu-labeled Anti-HER2 Nanobody
- (2014) Matthias D'Huyvetter et al. Theranostics
- Albumin as a versatile platform for drug half-life extension
- (2013) Darrell Sleep et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- In Vivo and In Vitro Studies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors
- (2013) Mohamed Altai et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Pharmacokinetics and Imaging of 212Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients
- (2013) Ruby F. Meredith et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate
- (2013) Amir Sabet et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
- (2013) John J. Zaknun et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Camelid single-domain antibody-fragment engineering for (pre)clinicalin vivomolecular imaging applications: adjusting the bullet to its target
- (2013) Jens De Vos et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis
- (2013) S. Put et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer
- (2013) C. Xavier et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies
- (2013) M Lemaire et al. LEUKEMIA
- Antibodies to watch in 2014
- (2013) Janice M Reichert mAbs
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Improvement of Radioimmunotherapy Using Pretargeting
- (2013) Eric Frampas et al. Frontiers in Oncology
- Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of 111In-Labeled Synthetic Anti-HER2 Affibody Molecules
- (2012) Anna Perols et al. BIOCONJUGATE CHEMISTRY
- Nanobody-Based Targeting of the Macrophage Mannose Receptor for EffectiveIn VivoImaging of Tumor-Associated Macrophages
- (2012) Kiavash Movahedi et al. CANCER RESEARCH
- Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
- (2012) Alexis Broisat et al. CIRCULATION RESEARCH
- Development of177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators
- (2012) Matthias D'Huyvetter et al. Contrast Media & Molecular Imaging
- Lutetium-labelled peptides for therapy of neuroendocrine tumours
- (2012) B. L. R. Kam et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
- (2012) M. J. W. D. Vosjan et al. MOLECULAR CANCER THERAPEUTICS
- Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
- (2012) Bart Cornelissen et al. NUCLEAR MEDICINE AND BIOLOGY
- Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody
- (2012) Marek Pruszynski et al. NUCLEAR MEDICINE AND BIOLOGY
- Molecular Theranostics: A Primer for the Imaging Professional
- (2011) Daniel Y. Lee et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET
- (2011) Maria J. W. D. Vosjan et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts
- (2011) Jennie Malmberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
- (2011) Ilse Vaneycken et al. FASEB JOURNAL
- A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
- (2011) Rob C. Roovers et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
- (2011) H. Wallberg et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical radioimmunotherapy—the role of radiobiology
- (2011) Jean-Pierre Pouget et al. Nature Reviews Clinical Oncology
- Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions
- (2011) A. Mishra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Radionuclide Therapy
- (2011) Devrim Ersahin et al. Cancers
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
- (2010) C. Zahnd et al. CANCER RESEARCH
- Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice
- (2010) Lea Olive Tchouate Gainkam et al. Contrast Media & Molecular Imaging
- Preliminary evaluation of 177Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy
- (2010) Lei Jiang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types
- (2010) K. De Groeve et al. JOURNAL OF NUCLEAR MEDICINE
- In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT
- (2010) I. Vaneycken et al. JOURNAL OF NUCLEAR MEDICINE
- Radioimmunotherapy of Lymphoma: Bexxar and Zevalin
- (2010) Stanley J. Goldsmith SEMINARS IN NUCLEAR MEDICINE
- Engineered affinity proteins for tumour-targeting applications
- (2009) Mikaela Friedman et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Engineered Knottin Peptides: A New Class of Agents for Imaging Integrin Expression in Living Subjects
- (2009) R. H. Kimura et al. CANCER RESEARCH
- Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
- (2009) Marleen Melis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
- (2009) Douglas Van Nostrand THYROID
- General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
- (2008) Cécile Vincke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT
- (2008) L. O. T. Gainkam et al. JOURNAL OF NUCLEAR MEDICINE
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More